• News
    • Tech News
    • AI
  • Gadgets
    • Apple
    • iPhone
  • Gaming
    • Playstation
    • Xbox
  • Science
    • News
    • Space
  • Streaming
    • Netflix
  • Vehicles
    • Car News
  • Social Media
    • WhatsApp
    • YouTube
  • Advertise
  • Terms
  • Privacy & Cookies
  • LADbible Group
  • LADbible
  • UNILAD
  • SPORTbible
  • GAMINGbible
  • Tyla
  • FOODbible
  • License Our Content
  • About Us & Contact
  • Jobs
  • Latest
  • Topics A-Z
  • Authors
Facebook
Instagram
X
TikTok
Snapchat
WhatsApp
Submit Your Content
Biotech boss working to bring back woolly mammoth and dodo hits back at Jurassic Park comparisons

Home> Science> News

Published 13:09 4 Mar 2025 GMT

Biotech boss working to bring back woolly mammoth and dodo hits back at Jurassic Park comparisons

In a bid to de-extinct ancient animals, the team have created a 'woolly mouse'

Rikki Loftus

Rikki Loftus

Featured Image Credit: MARK GARLICK/SCIENCE PHOTO LIBRARY/Getty Images
Science
News

Advert

Advert

Advert

A biotech boss is working on achieving what many have considered to be the impossible by bringing the woolly mammoth back from the dead.

But despite this incredible feat, the CEO has hit back at comparisons made to Jurassic Park.

Ben Lamm is the founder and head of Colossal Biosciences, a firm that is working to revive ancient creatures that no longer roam our planet.

These include the woolly mammoth and the dodo bird.

While you’d be forgiven for thinking this is very reminiscent of a certain 1993 Steven Spielberg film, Lamm disagrees.

Advert

Speaking to UNILAD Tech, he said: “Jurassic Park was a super entertaining, super interesting movie that wasn’t real.

“People will be like, ‘but didn’t they see Jurassic Park?’ Yeah, I also saw Blade Runner, I saw Dune, I saw a lot of other things that aren’t real.

“One of the things that I think Jurassic Park did a great job of is Mr DNA taught kids and everyone that there’s this thing called DNA. It’s made up of these letters, and we as humanity now have these tools that can edit and change it, and that inspires people.”

Lamm continued: “We actually have a lot of scientists that we work with. I won’t name names… that say that Jurassic Park was one of the reasons why they wanted to go into genetics.

Advert

“They don’t want to bring back dinosaurs, but they just inspired them and got them excited.”

Instead, the biotech company has its sights on bringing back other ancient creatures and right now, they are focussed on the woolly mammoth.

Lamm had previously shared that his team hopes to have a living mammoth back on Earth by late 2028.

And now, they’ve made a new breakthrough by creating a ‘woolly mouse’.

Advert

The biotech firm hope that the woolly mammoth will one day walk the Earth again (MARK GARLICK/SCIENCE PHOTO LIBRARY/Getty Images)
The biotech firm hope that the woolly mammoth will one day walk the Earth again (MARK GARLICK/SCIENCE PHOTO LIBRARY/Getty Images)

While the experts clarified that they didn’t just ‘shove a mammoth gene into a mouse’, instead the team focussed on certain mammoth traits like ‘woolly hair’ and ‘thicker layers of fat’, to narrow down which genes to select. And thus, the woolly mouse was born.

While the genetically modified mice will help the scientists narrow down the traits for their mammoths, they don’t intend to stop there.

The firm has hopes of ‘de-extincting’ other animals that are no longer with us including the dodo and the thylacine, which is better known as the Tasmanian tiger.

How will this technology help endangered animals?

But de-extinction isn’t the only focus for Colossal Biosciences as they are using the groundbreaking technology to save animals before they reach extinction.

Advert

Lamm said: “Don’t get me wrong, the woolly mouse is pretty damn cute and mammoths are amazing, but people want to only talk for the most part about de-extinction.

The team of scientists have created the 'woolly mouse' as part of their de-extinction project (Colossal Biosciences)
The team of scientists have created the 'woolly mouse' as part of their de-extinction project (Colossal Biosciences)

“You know, what’s funny is, we have more species preservation and conservation projects going on than de-extinction projects.

“And with some of those, some of the work that we’ve done around elephant disease (EEHV) that’s killing 20% of elephants every year, some of the work that we’re doing on the Northern White Rhinos, or the other work that we’re doing around the world has produced some very quick results from a conservation perspective.”

Advert

And if something isn’t done to protect our wildlife, we’re facing a pretty bleak future, according to the biotech boss.

Lamm added: “We are in an extinction crisis. We’re in the sixth mass extinction, it’s caused by humans. We’re going to lose up to 50% of biodiversity between now and 2050.

“We have to build new tools and technologies, and we just want to be one very small player helping with that movement.”

Choose your content:

2 days ago
3 days ago
  • 2 days ago

    California resident catches the plague after being bitten in popular vacation spot

    The medieval disease killed up to 200 million people in the 14th century

    Science
  • 2 days ago

    Antarctic Ice Sheet on the verge of a 'catastrophic' collapse causing irreversible damage

    It could have a catastrophic effect on the global sea level

    Science
  • 2 days ago

    Harvard expert issues chilling warning that strange object heading towards Earth may be a ‘mothership'

    An alien invasion could be on the cards

    Science
  • 3 days ago

    Scientists warn infected deer could potentially kill human with deadly plague

    Supposed 'zombie deer' feel like Resident Evil brought to life

    Science
  • 'Hostile' comet aimed at Earth could obliterate the world's economy 'overnight' if it hits
  • Biotech boss says a living mammoth is 'highly likely' to be walking Earth again sooner than people think
  • Groundbreaking drug can 'bring brain back to life' as Parkinson's reversal hope grows
  • Shocking study links use of Ozempic to sudden vision loss and increased risk of rare eye conditions